服务电话(移):17319309550
≥98% (HPLC), solid
329770820
DMSO: ≥20 mg/mL, clear, light yellow;H2O: insoluble
AR-A014418 has been used as an inhibitor of glycogen synthase kinase 3 (GSK3).
AR-A014418 may have chronic pain-relieving properties. In mice having neuropathic pain, this molecule has been shown to have antihyperalgesic effects. AR-A014418 may modulate proinflammatory cytokines and the catecholaminergic and serotonergic pathways. It has also been studied that AR-A014418 inhibits growth of pancreatic cancer cells.
Glycogen synthase kinase 3 (GSK3) is a serine/threonine kinase that has been implicated in pathological conditions such as diabetes and Alzheimer′s disease. GSK3 inhibitor, AR-A014418, inhibits GSK3 (IC₅₀ = 104 nM), in an ATP-competitive manner (Ki = 38 nM). AR-A014418 does not significantly inhibit cdk2 or cdk5 (IC₅₀> 100 μM) or 26 other kinases, demonstrating high specificity for GSK3.
This compound was developed by AstraZeneca. To browse the list of other pharma-developed compounds and Approved Drugs/Drug Candidates, click here.
好评度 | 商品满意度 | 服务满意度 | 发货满意度 |
"A3230-25MG,AR-A014418"商品可能已被商家删除,您可查看其他相似商品!
相似产品推荐